Peripheral Artery Disease (PAD)

This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia. 

Mercator MedSystems, Bullfrog Micro-Infusion Device, DANCE trial, VIVA 2016, 13-month results
News | Peripheral Artery Disease (PAD) | October 07, 2016

October 7, 2016 — Mercator MedSystems recently announced that 13-month data from the DANCE trial was presented...

TCT 2016, TCT.16, main arena, late breaking trials
Feature | Cath Lab | September 28, 2016

September 28, 2016 — The Cardiovascular Research Foundation (CRF) included 11 late-breaking trials and 16 first...

Bard, Lutonix 014 DCB, drug-coated balloon, six-month endpoint, FDA IDE trial
Technology | Drug-Eluting Balloons | September 26, 2016

September 26, 2016 — C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approved an...

Medtronic, In.Pact Admiral drug-coated balloon, trial data, VIVA
News | Drug-Eluting Balloons | September 22, 2016

September 22, 2016 — New data presented at the Vascular Interventional Advances (VIVA) conference demonstrated the...

Shockwave medical, lithoplasty
News | Cath Lab | September 19, 2016

September 19, 2016 — Shockwave Medical announced positive clinical results from the pooled DISRUPT PAD Study, a...

lithoplasty, lithotripsy for arteries

The Shockwave Medical Lithoplasty system combines a balloon catheter with tiny lithotripsy electrodes that emit pulses to crack and break up calcium in peripheral arteries.

Technology | Peripheral Artery Disease (PAD) | September 16, 2016

September 16, 2016 — The U.S. Food and Drug Administration (FDA) has granted market clearance for Shockwave Medical’...

Videos | Peripheral Artery Disease (PAD) | September 16, 2016

This video, provided by Shockwave Medical, demonstrates the Lithoplasty System. It uses ultrasonic waves to...

VIVA 2016, late breaking trials, cath lab
Feature | Cath Lab | September 14, 2016

Vascular Interventional Advances (VIVA) 2016 released its list late-breaking research presentations in vascular...

Intact Vascular, TOBA clinical study, one-year results, Tack Endovascular System, Journal of Vascular Surgery
News | Peripheral Artery Disease (PAD) | August 24, 2016

August 24, 2016 — Intact Vascular Inc. announced that the one-year results from its Tack Optimized Balloon...

News | Peripheral Artery Disease (PAD) | August 22, 2016

August 22, 2016 — Avinger Inc. recently announced the closing of its previously announced public offering of 9,857,...

Covidien, Medtronic, TurboHawk, Atherectomy system

The Medtronic TurboHawk atherectomy system. 

Feature | Atherectomy Devices | August 18, 2016 | Dave Fornell

Due to poor outcomes from percutaneous transluminal angioplasty (PTA) ballooning of vessels alone, or of stenting in...

Cardiovascular Systems Inc., LIBERTY 360 study, Amputation Prevention Symposium, PAD, peripheral artery disease, atherectomy
News | Peripheral Artery Disease (PAD) | August 16, 2016

August 16, 2016 — Cardiovascular Systems Inc. (CSI) released procedural and 30-day results from its LIBERTY 360°...

Mercator, Bullfrog Micro-infusion Device, below-the-knee, critical limb ischemia, CLI, LIMBO-ATX trial, first patients enrolled
News | Peripheral Artery Disease (PAD) | August 10, 2016

August 10, 2016 — Mercator MedSystems Inc. announced the enrollment of the first critical limb ischemia (CLI)...

Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves. 

Feature | August 05, 2016 | Dave Fornell

 

August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional...

Gore, Tigris stent, fluoropolymer nitinol stent, peripheral artery disease

The Gore Tigris is a dual-component stent with a unique fluoropolymer / nitinol design.

Technology | Stents Peripheral | August 02, 2016

August 2, 2016 —The U.S. Food and Drug Administration (FDA) granted market clearance for W. L. Gore & Associates...

Overlay Init